Year |
Citation |
Score |
2018 |
Ohmine S, Salisbury JL, Ingle J, Pettinato G, Haddox CL, Haddad T, Galanis E, Ikeda Y, D'assoro AB. Aurora-A overexpression is linked to development of aggressive teratomas derived from humans iPS cells. Oncology Reports. PMID 29393405 DOI: 10.3892/Or.2018.6239 |
0.545 |
|
2016 |
El Khatib MM, Ohmine S, Jacobus EJ, Tonne JM, Morsy SG, Holditch SJ, Schreiber CA, Uetsuka K, Fusaki N, Wigle DA, Terzic A, Kudva YC, Ikeda Y. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration. Stem Cells Translational Medicine. PMID 26987352 DOI: 10.5966/Sctm.2015-0017 |
0.511 |
|
2014 |
Sukegawa S, Sakuma R, Ohmine S, Takeuchi H, Ikeda Y, Yamaoka S. Suppressor of cytokine signaling 1 counteracts rhesus macaque TRIM5α-induced inhibition of human immunodeficiency virus type-1 production. Plos One. 9: e109640. PMID 25310711 DOI: 10.1371/Journal.Pone.0109640 |
0.596 |
|
2014 |
D'Assoro AB, Liu T, Quatraro C, Amato A, Opyrchal M, Leontovich A, Ikeda Y, Ohmine S, Lingle W, Suman V, Ecsedy J, Iankov I, Di Leonardo A, Ayers-Inglers J, Degnim A, et al. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells. Oncogene. 33: 599-610. PMID 23334326 DOI: 10.1038/Onc.2012.628 |
0.506 |
|
2014 |
Sukegawa S, Sakuma R, Ohmine S, Takeuchi H, Ikeda Y, Yamaoka S. SOCS1 is detected in purified HIV-1 VLPs. Plos One. DOI: 10.1371/Journal.Pone.0109640.G003 |
0.372 |
|
2013 |
Ohmine S, Singh RD, Marks DL, Meyer MA, Pagano RE, Ikeda Y. Viral attachment induces rapid recruitment of an innate immune sensor (TRIM5α) to the plasma membrane. Journal of Innate Immunity. 5: 414-24. PMID 23548691 DOI: 10.1159/000346963 |
0.572 |
|
2013 |
Thatava T, Kudva YC, Edukulla R, Squillace K, De Lamo JG, Khan YK, Sakuma T, Ohmine S, Terzic A, Ikeda Y. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 228-39. PMID 23183535 DOI: 10.1038/Mt.2012.245 |
0.543 |
|
2012 |
Kudva YC, Ohmine S, Greder LV, Dutton JR, Armstrong A, De Lamo JG, Khan YK, Thatava T, Hasegawa M, Fusaki N, Slack JM, Ikeda Y. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Translational Medicine. 1: 451-61. PMID 23197849 DOI: 10.5966/Sctm.2011-0044 |
0.532 |
|
2012 |
Ohmine S, Squillace KA, Hartjes KA, Deeds MC, Armstrong AS, Thatava T, Sakuma T, Terzic A, Kudva Y, Ikeda Y. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging. 4: 60-73. PMID 22308265 |
0.489 |
|
2012 |
Sakuma T, Tonne JM, Malcolm JA, Thatava T, Ohmine S, Peng KW, Ikeda Y. Long-term infection and vertical transmission of a gammaretrovirus in a foreign host species. Plos One. 7: e29682. PMID 22235324 DOI: 10.1371/Journal.Pone.0029682 |
0.513 |
|
2011 |
Thatava T, Armstrong AS, De Lamo JG, Edukulla R, Khan YK, Sakuma T, Ohmine S, Sundsbak JL, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Research & Therapy. 2: 48. PMID 22142803 DOI: 10.1186/Scrt89 |
0.529 |
|
2011 |
Ohmine S, Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T, Sakuma T, Kudva YC, Ikeda Y. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Research & Therapy. 2: 46. PMID 22088171 DOI: 10.1186/Scrt87 |
0.548 |
|
2011 |
Tonne JM, Campbell JM, Cataliotti A, Ohmine S, Thatava T, Sakuma T, Macheret F, Huntley BK, Burnett JC, Ikeda Y. Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes. Clinical Chemistry. 57: 864-73. PMID 21482747 DOI: 10.1373/Clinchem.2010.157438 |
0.472 |
|
2011 |
Sakuma T, Hué S, Squillace KA, Tonne JM, Blackburn PR, Ohmine S, Thatava T, Towers GJ, Ikeda Y. No evidence of XMRV in prostate cancer cohorts in the Midwestern United States Retrovirology. 8. PMID 21447170 DOI: 10.1186/1742-4690-8-23 |
0.484 |
|
2011 |
Ohmine S, Sakuma R, Sakuma T, Thatava T, Takeuchi H, Ikeda Y. The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production. Plos One. 6: e16121. PMID 21264255 DOI: 10.1371/Journal.Pone.0016121 |
0.576 |
|
2011 |
Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, Peng KW, Barry MA, Ikeda Y. Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. Journal of Virology. 85: 1205-13. PMID 21084477 DOI: 10.1128/Jvi.00886-10 |
0.548 |
|
2011 |
Thatava T, Nelson TJ, Edukulla R, Sakuma T, Ohmine S, Tonne JM, Yamada S, Kudva Y, Terzic A, Ikeda Y. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Therapy. 18: 283-93. PMID 21048796 DOI: 10.1038/Gt.2010.145 |
0.522 |
|
2010 |
Ohmine S, Sakuma R, Sakuma T, Thatava T, Solis GP, Ikeda Y. Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction. The Journal of Biological Chemistry. 285: 34508-17. PMID 20810659 DOI: 10.1074/Jbc.M110.158188 |
0.509 |
|
2010 |
Sakuma T, De Ravin SS, Tonne JM, Thatava T, Ohmine S, Takeuchi Y, Malech HL, Ikeda Y. Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein. Human Gene Therapy. 21: 1665-73. PMID 20507233 DOI: 10.1089/Hum.2010.063 |
0.592 |
|
2010 |
Sakuma R, Sakuma T, Ohmine S, Silverman RH, Ikeda Y. Xenotropic murine leukemia virus-related virus is susceptible to AZT. Virology. 397: 1-6. PMID 19959199 DOI: 10.1016/J.Virol.2009.11.013 |
0.569 |
|
2010 |
Sakuma R, Ohmine S, Ikeda Y. Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication. The Journal of Biological Chemistry. 285: 3784-93. PMID 19951947 DOI: 10.1074/Jbc.M109.059063 |
0.565 |
|
2008 |
Murray BK, Ohmine S, Tomer DP, Jensen KJ, Johnson FB, Kirsi JJ, Robison RA, O'Neill KL. Virion disruption by ozone-mediated reactive oxygen species. Journal of Virological Methods. 153: 74-7. PMID 18598719 DOI: 10.1016/J.Jviromet.2008.06.004 |
0.307 |
|
2008 |
Sakuma R, Ohmine S, Mael AA, Noser JA, Ikeda Y. Reply to: No effect of endogenous TRIM5α on HIV-1 production Nature Medicine. 14: 236-238. DOI: 10.1038/Nm0308-236 |
0.53 |
|
2007 |
Noser JA, Mael AA, Sakuma R, Ohmine S, Marcato P, Wk Lee P, Ikeda Y. The RAS/Raf1/MEK/ERK Signaling Pathway Facilitates VSV-mediated Oncolysis: Implication for the Defective Interferon Response in Cancer Cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1531-1536. PMID 28182875 DOI: 10.1038/sj.mt.6300193 |
0.485 |
|
2007 |
Noser JA, Mael AA, Sakuma R, Ohmine S, Marcato P, Lee PW, Ikeda Y. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1531-6. PMID 17505473 DOI: 10.1038/Sj.Mt.6300193 |
0.532 |
|
2007 |
Sakuma R, Noser JA, Ohmine S, Ikeda Y. Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins. Nature Medicine. 13: 631-5. PMID 17435772 DOI: 10.1038/Nm1562 |
0.587 |
|
2007 |
Sakuma R, Noser JA, Ohmine S, Ikeda Y. Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G. Gene Therapy. 14: 185-9. PMID 16943852 DOI: 10.1038/Sj.Gt.3302852 |
0.59 |
|
Show low-probability matches. |